Knee Osteoarthritis with Stage 1 Hypertension in an Elderly Patient: A Case Report
DOI:
https://doi.org/10.53089/medula.v17i1.1956Keywords:
Ederly, hypertension, NSAIDs, obesity, osteoarthritisAbstract
Osteoarthritis (OA) and hypertension are chronic degenerative diseases commonly found in older adults and share interrelated pathophysiological mechanisms that may exacerbate each other through vascular, inflammatory, and functional decline pathways. This case report aims to describe a comprehensive approach in a patient with knee OA and stage 1 hypertension. A 62-year-old woman presented with chronic left knee pain that worsened with activity, accompanied by morning stiffness lasting less than 30 minutes. The patient had a history of uncontrolled hypertension and obesity with a body mass index of 27.6 kg/m². The diagnosis of knee OA and stage 1 hypertension was established based on history taking, physical examination, and clinical investigations. Management was performed comprehensively using pharmacological therapy consisting of sodium diclofenac, omeprazole, and amlodipine, along with non-pharmacological interventions including patient education, lifestyle modification, weight control, increased physical activity, and dietary adjustment. Particular attention was given to NSAID use in patients with cardiometabolic risk factors due to the potential for increased blood pressure and cardiovascular risk, necessitating careful risk–benefit consideration and regular clinical monitoring. Follow-up evaluation demonstrated improvement in blood pressure and reduction in pain, leading to enhanced daily functional capacity. This case highlights the importance of a multidimensional approach in OA with comorbid hypertension, focusing not only on symptom control but also on cardiovascular risk stratification, analgesic safety, and sustained lifestyle interventions to improve therapeutic outcomes and patient quality of life.
References
Fatihaturahmi Y, Yuliana Y, Yulastri A. Literature review: Penyakit degeneratif: Penyebab, akibat, pencegahan dan penanggulangan. Jurnal Gizi dan Kesehatan (JGK). 2023;3(1):63–72.
Kolasinski SL, Neogi T, Hochberg MC, Oatis C, Guyatt G, Block J, dkk. 2019 American College of Rheumatology/ Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Rheumatol. 2020;72(2):220–233.
Courties A, Kouki I, Soliman N, Mathieu S, Sellam J. Osteoarthritis year in review 2024: Epidemiology and therapy. Osteoarthritis Cartilage. 2024;32(11): 1397–1404.
Badan Penelitian dan Pengembangan Kesehatan. Laporan Nasional Riskesdas 2018. Jakarta: Kementerian Kesehatan Republik Indonesia; 2019.
Yucesoy B, Charles LE, Baker B, Burchfiel CM. Occupational and genetic risk factors for osteoarthritis: A review. Work. 2015;50(2):261–273.
Kementerian Kesehatan Republik Indonesia. Buku Pedoman Hipertensi 2024. Jakarta: Direktorat P2PTM, Ditjen P2P; 2024.
World Health Organization. Hypertension – Fact sheet [internet]. Geneva: World Health Organization; 2023 [disitasi tanggal 29 Mei 2026]. Tersedia dari: https://www.who.int/news-room/fact-sheets/detail/hypertension
Kementerian Kesehatan Republik Indonesia. Survei Kesehatan Indonesia (SKI) 2023. Jakarta: Kementerian Kesehatan RI; 2024.
Liu R, Li Y, Cai Z, dkk. Association between hypertension and osteoarthritis: A systematic review and meta-analysis. BMC Musculoskelet Disord. 2022;23:458.
Piszczatoski CR, Smith SM. Pharmacological considerations when treating hypertensive patients for osteoarthritis. Expert Opin Pharmacother. 2022;23(15):1673–1676.
Moseng T, Vliet Vlieland TPM, Battista S, Beckwée D, Boyadzhieva V, Conaghan PG, dkk. EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis: 2023 update. Ann Rheum Dis. 2024;83(6):730–740.
Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet. 2019;393(10182): 1745–1759.
Wijaya S. Osteoartritis lutut. Cermin Dunia Kedokteran. 2018;45(6):424–429.
Kementerian Kesehatan Republik Indonesia. Pedoman Nasional Pelayanan Klinis Tata Laksana Obesitas Dewasa. Jakarta: Kementerian Kesehatan RI; 2025.
Perhimpunan Reumatologi Indonesia (IRA). Rekomendasi untuk diagnosis dan penatalaksanaan osteoartritis. Jakarta: IRA; 2014.
Kreutz R, Brunström M, Burnier M, Grassi G, Januszewicz A, Muiesan ML, dkk. 2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension. Eur J Intern Med. 2024;126:1–15.
Moore N. Coronary risks associated with diclofenac and other NSAIDs: An update. Drug Saf. 2020;43(4):301–318.
Ching K, Houard X, Berenbaum F, dkk. Hypertension meets osteoarthritis — revisiting the vascular aetiology hypothesis. Nat Rev Rheumatol. 2021;17:533–549.
Visseren FLJ, Mach F, Smulders YM, dkk. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227–3337.
Kolasinski SL, Neogi T, Hochberg MC, Oatis C, Guyatt G, Block J, dkk. 2019 American College of Rheumatology/ Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2020;72(2):149–162.
Lanza FL, Chan FKL, Quigley EMM. Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol. 2009;104(3):728–738.
Conley B, Bunzli S, Bullen J, O’Brien P, Persaud J, Gunatillake T, dkk. Core recommendations for osteoarthritis care: A systematic review of clinical practice guidelines. Arthritis Care Res (Hoboken). 2023;75(9):1897–1907.
Kementerian Kesehatan Republik Indonesia. Pedoman Nasional Pelayanan Kedokteran Tata Laksana Hipertensi Dewasa. Jakarta: Kementerian Kesehatan RI; 2021.
James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, dkk. 2014 Evidence-based guideline for the management of high blood pressure in adults. JAMA. 2014;311(5):507–520.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Medical Profession Journal of Lampung

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.











